Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
The final trial focused on urolithin A for photodamaged skin (damage caused by UV light) and found that a 1% urolithin A treatment reduced skin redness by 14% versus placebo, meaning it could protect photodamaged skin or promote its healing after exposure.29 Muscle function and recovery According to a 2023 review, urolithin A may promote muscle protein synthesis and mitigate muscle atrophy while improving muscle health and performance due to its effects on mitophagy.23 Additionally, a 2022 study on Mitopure found that daily doses of 500mg and 1,000mg (or 1g) for four months increased subjects leg muscle strength and, in the 1,000mg dose group, boosted their aerobic endurance.5 Timeline Mitopure and Mito-Biotic Best overall, best powdered urolithin A, and best topical urolithin A Photo by Innerbody Research Pros Branded form of urolithin A that has been examined in over a dozen studies Dose of urolithin A is clinically relevant Supplements are NSF Certified for Sport Received favorable Generally Recognized as Safe (GRAS) review from the FDA Products are non-GMO, vegan, cruelty-free, gluten-free, and free from major allergens Skincare should be sensitive-skin friendly (no dyes or fragrances) Supplements available in capsule, gummy, and powder forms All products are HSA/FSA eligible through Truemed Subscriptions can save you 10-32% off, depending on product and delivery interval 30-day money-back guarantee on supplements Cons Guarantee doesnt apply to skincare products More expensive than other urolithin A supplements Capsules may leak, leading to wasted product and mess Inactive ingredients in supplements may trigger rare allergies Subscription management requires contacting customer service No subscription customization available Products werent packed very safely The Timeline brand is owned and operated by Amazentis SA, the Swiss life sciences company that developed Mitopure
IASLC 2014, 2014
Fomenko DE, Marino SM, Gladyshev VN
doi: 10.1902/jop.2013.1340011 23 ChenH.BurkeC.DonovanC.FaizA.SaadS.OliverB
PMID: 15299043
